Home/Filings/4/0001209191-22-014798
4//SEC Filing

Goldberg John Mayer 4

Accession 0001209191-22-014798

CIK 0001671818other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:50 PM ET

Size

8.8 KB

Accession

0001209191-22-014798

Insider Transaction Report

Form 4
Period: 2022-03-01
Goldberg John Mayer
SVP, Clinical Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-03-01+84,50084,500 total
    Exercise: $2.00Exp: 2032-02-29Common Stock (84,500 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service through each such vesting date.

Issuer

Oncorus, Inc.

CIK 0001671818

Entity typeother

Related Parties

1
  • filerCIK 0001826549

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:50 PM ET
Size
8.8 KB